$60M Mylan Securities Settlement — Claim by Jul 10, 2026

Mylan $60 million securities class action settlement — MYL stock investors 2016–2019

Published: March 16, 2026

Status Claims Open

Claim Deadline July 10, 2026 final approval hearing June 15, 2026 at 10:00 a.m. ET · opt-out/objection deadline was May 15, 2026

Estimated Payout ~$0.11 per eligible share (before fees) $60,000,000 cash fund · pro rata by Recognized Loss · no payment under $10.00

Proof Required Yes brokerage statements or trade confirmations of your MYL trades

What Is the Mylan Securities Settlement About?

If you bought stock in Mylan — the pharmaceutical company best known for making the EpiPen — at any point between February 2016 and May 2019, you may be owed money from a $60 million securities class action settlement. Here is what happened and what it means for you, in plain English.

The case is In re Mylan, N.V. Securities Litigation, Master File No. 2:20-cv-00955-NR, pending in the U.S. District Court for the Western District of Pennsylvania. The parties agreed to settle for $60,000,000 after a mediation session in December 2025. Mylan denied all allegations, and the court did not decide who was right — the settlement is a compromise that ends the litigation and provides a guaranteed cash recovery for the class.

What Is Mylan?

Mylan N.V. was one of the largest generic and specialty pharmaceutical companies in the world. If you have ever used a generic prescription drug, there is a good chance it was made by Mylan. The company was best known for manufacturing the EpiPen — the emergency epinephrine injector used by millions of people with severe allergies. Mylan also made hundreds of other generic medications, from blood pressure drugs to antibiotics to HIV treatments.

During the time period covered by this settlement, Mylan's stock traded on the NASDAQ stock exchange under the ticker symbol MYL. If you owned shares through a brokerage account, a retirement account like an IRA or 401(k), or any other investment account, you may have held Mylan stock.

After the class period ended, Mylan merged with Upjohn — a division of Pfizer — in November 2020 to form a new company called Viatris (NASDAQ: VTRS). If you held Mylan stock through the merger, your shares were converted to Viatris shares.

What Is a Securities Class Action?

When you buy stock in a company, you are relying on the company's public statements — earnings reports, press releases, SEC filings — to be accurate. Federal securities laws require companies to tell the truth about their business. If a company or its executives make false or misleading statements that artificially inflate the stock price, and you buy stock at that inflated price, you lose money when the truth comes out and the stock drops. A securities class action is a lawsuit filed on behalf of all the investors who were harmed by those misrepresentations. Instead of each investor filing a separate lawsuit, one lawsuit covers everyone.

A settlement means the company agrees to pay a sum of money to compensate those investors rather than risk a trial. The money is distributed proportionally based on when you bought, how many shares you held, and when (or if) you sold.

What Did Mylan Allegedly Do?

The lawsuit alleged that Mylan and three of its top executives made false and misleading statements about FDA inspections and regulatory compliance problems at Mylan's manufacturing facilities around the world.

In plain terms, the FDA inspects pharmaceutical manufacturing plants to make sure drugs are being made safely and correctly. When problems are found, the FDA issues compliance notices (such as warning letters or Form 483 observations). The lawsuit claimed Mylan's executives downplayed or concealed the severity of these FDA findings, making investors believe the company's manufacturing operations were in better shape than they actually were. This allegedly kept Mylan's stock price artificially high.

When the truth came out through a series of disclosures in 2018 and 2019 — on June 27, 2018, August 8, 2018, February 26, 2019, and May 7, 2019 — Mylan's stock price dropped significantly. Investors who bought shares at the inflated prices lost money. Mylan denied all allegations, and the settlement is not an admission of liability by anyone.

Do I Qualify?

You qualify if you purchased or otherwise acquired publicly traded common stock of Mylan N.V. (NASDAQ: MYL) between February 16, 2016 and May 7, 2019 (inclusive) and were damaged as a result.

To receive any payment, you must have held your shares through at least one of the corrective disclosure dates — June 27, 2018, August 8, 2018, February 26, 2019, or May 7, 2019. If you bought and sold all your Mylan stock before June 27, 2018, your recognized loss is zero.

This includes shares held in brokerage accounts, retirement accounts (IRAs, 401(k)s), and any other investment accounts. If you held Mylan stock through an employer retirement plan (ERISA plan), only shares purchased outside of that plan are eligible — the plan's trustees may file separately for shares held within the plan.

How Much Can You Get?

The total settlement fund is $60 million. After deductions for attorneys' fees (up to 25% of the fund), litigation expenses (up to $500,000), administration costs, and taxes, the remaining net settlement fund is distributed to claimants based on a formula that considers when you bought, how many shares you held, and when you sold.

The estimated average recovery is approximately $0.11 per eligible share before fee deductions. Your actual payment could be higher or lower depending on your specific transactions and how many claims are filed. If your calculated distribution amount is less than $10.00, no payment will be made.

How Do I File a Claim?

You must submit a claim form with supporting documentation showing your Mylan stock transactions during the class period. This means brokerage statements, trade confirmations, or similar records showing the dates you bought and sold Mylan shares and the prices you paid.

Claims can be submitted online at the official settlement website or by mail. The deadline is July 10, 2026.

Keep in mind: the settlement administrator does not have your transaction records. You must provide them yourself. If you no longer have your brokerage statements, contact your broker or financial institution to request copies. If you lost your notice or need help, use the contact form on the official settlement website rather than responding to unsolicited messages.

Claim Form Website: Mylan2026SecuritiesSettlement.com

Submit Claim

Key Mylan Settlement Deadlines

• Class Period: February 16, 2016 through May 7, 2019 (inclusive)
• Opt-out (exclusion) deadline: May 15, 2026
• Objection deadline: May 15, 2026
• Claim Form deadline: submitted online or postmarked by July 10, 2026
• Final Approval Hearing: June 15, 2026 at 10:00 a.m. ET (via Zoom)

What Happens If I Do Nothing?

If you do nothing, you will not receive any payment. You will still be bound by the settlement and give up your right to sue Mylan separately over the same claims. To be eligible for your share of the $60 million, you must file a claim by July 10, 2026.

Watch Out for Settlement Scams

With any securities settlement, be cautious about how you file and who you share information with:

• Use the official Settlement Website only: Mylan2026SecuritiesSettlement.com. Bookmark it, and be wary of emails or texts linking to a similar-looking page on a different domain.
• Never pay a fee. Legitimate class action settlements never charge an activation, release, or processing fee to send you your money.
• Share only what is needed. The Claims Administrator needs your transaction documentation and contact details — not banking passwords or unrelated personal data.

Frequently Asked Questions About the Mylan Settlement

How much will I get from the Mylan settlement?

The estimated average recovery is approximately $0.11 per eligible share of Mylan common stock, before deductions for attorneys' fees and expenses. Your actual payment depends on when you bought and sold your shares and how many valid claims are filed. The total settlement fund is $60 million, and no payment under $10.00 will be distributed.

Who qualifies for the Mylan securities settlement?

All persons and entities who purchased or otherwise acquired publicly traded common stock of Mylan N.V. (NASDAQ: MYL) between February 16, 2016 and May 7, 2019, inclusive, and were damaged as a result. You must have held your shares through at least one of the corrective disclosure dates (June 27, 2018, August 8, 2018, February 26, 2019, or May 7, 2019) to have a recognized loss.

What is a securities class action settlement?

A securities class action is a lawsuit filed on behalf of investors who bought stock in a company and lost money because the company or its executives allegedly made false or misleading statements that inflated the stock price. When the truth comes out and the stock price drops, investors who bought at the inflated price suffer losses. A settlement means the company agrees to pay a sum of money to compensate those investors instead of going to trial.

What did Mylan allegedly do wrong?

The lawsuit alleged that Mylan and three of its top executives made false and misleading statements about FDA inspections and regulatory compliance at Mylan manufacturing facilities. Investors alleged these misrepresentations inflated Mylan's stock price, and when the truth was revealed through a series of disclosures in 2018 and 2019, the stock price declined significantly. Mylan denied all allegations.

What proof do I need to file a Mylan claim?

Yes, documentation is required. You must submit a claim form with brokerage statements or trade confirmations showing the dates, share quantities, and prices of your Mylan (MYL) purchases and sales during the class period. The settlement administrator does not have your transaction records, so you must provide them yourself.

Official Settlement Notice

Sources

• Notice of Pendency and Proposed Settlement of Class Action, In re Mylan, N.V. Securities Litigation, Master File No. 2:20-cv-00955-NR (W.D. Pa.)
• Proof of Claim and Release Form, In re Mylan, N.V. Securities Litigation
• Official Settlement Website: Mylan2026SecuritiesSettlement.com
• Lead Counsel: Bernstein Litowitz Berger & Grossmann LLP; Kessler Topaz Meltzer & Check, LLP
• Claims Administrator: JND Legal Administration

Filing Class Action Settlement Claims

Please submit only truthful information through the official Settlement Website, and document your MYL transactions accurately. The official Settlement Website is the authoritative source for benefit amounts, deadlines, and filing instructions. If you are unsure whether you qualify, contact the Claims Administrator through the Settlement Website. OpenClassActions.com is a consumer news site and is not the Claims Administrator, Lead Counsel, or a law firm, and we do not process or decide claims.

Settlement Amount $60,000,000

Case Title In re Mylan, N.V. Securities Litigation

Case Number 2:20-cv-00955-NR

Court U.S. District Court, Western District of Pennsylvania

Class Period February 16, 2016 – May 7, 2019

Claim Deadline July 10, 2026

Final Approval Hearing June 15, 2026 at 10:00 a.m. ET via Zoom

Lead Counsel Bernstein Litowitz Berger & Grossmann LLP; Kessler Topaz Meltzer & Check, LLP

Administrator JND Legal Administration

Official Website Mylan 2026 Securities Settlement.com

For more class actions keep scrolling below.